Bala V. ManyamMuralikrishnan DhanasekaranJohn M. Cassady
Parkinson’s disease (also known as paralysis agitans or shaking palsy) is a nervous system degenerative illness caused by a lack of or interference with the neurotransmitter dopamine in the basal ganglia. Hypokinetic movement problems, such as resting tremors, muscle stiffness, poverty of movement, trouble with balance and walking, sadness, and dementia, are all symptoms of the condition.As individuals live longer, the number of persons at risk of acquiring Parkinson’s disease rises. A formulation for the treatment of Parkinson’s disease has been discovered using an unique way of extracting Mucuna pruriens cotyledons, which gives effective rapid alleviation of symptoms while also slowing the disease process. The Mucuna pruriens cotyledon extract of the present invention has a particular benefit over existing Mucuna pruriens powder and extract preparations since it may be administered to patients via numerous modes of administration, including injection.